Page last updated: 2024-09-04

cyc 202 and Diabetic Nephropathies

cyc 202 has been researched along with Diabetic Nephropathies in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, X; Liu, W; Wang, S; Zhang, Y; Zhao, H; Zhao, X; Zhou, Y1
Hao, J; Li, H; Liu, W; Zhang, Y; Zhou, Y1
Bai, X; Geng, J; Hou, X; Li, X; Tian, J1
Duan, H; Hao, J; Liu, Q; Liu, S; Liu, W; Shi, Y; Zhang, Y; Zhao, S1

Other Studies

4 other study(ies) available for cyc 202 and Diabetic Nephropathies

ArticleYear
Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 115

    Topics: Animals; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney; Kidney Function Tests; Male; Mice, Inbred Strains; p38 Mitogen-Activated Protein Kinases; Roscovitine; Signal Transduction; Streptozocin; Transforming Growth Factor beta

2019
High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
    Experimental cell research, 2014, Aug-15, Volume: 326, Issue:2

    Topics: Animals; Apoptosis; Benzamides; Cells, Cultured; Cyclin-Dependent Kinase 5; Diabetic Nephropathies; Dioxoles; Early Growth Response Protein 1; Gene Knockdown Techniques; Glucose; Mice; Phosphotransferases; Podocytes; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Purines; Rats; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Roscovitine; Signal Transduction; Transforming Growth Factor beta1; Up-Regulation

2014
CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via ERK1/2/PPARγ pathway.
    Oncotarget, 2016, Jun-14, Volume: 7, Issue:24

    Topics: Adult; Animals; Cell Line; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Female; Fibrosis; Glucose; Humans; Kidney Tubules; Male; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; PPAR gamma; Protein Kinase Inhibitors; Purines; Rats, Sprague-Dawley; Roscovitine; Signal Transduction

2016
The expression of intermediate filament protein nestin and its association with cyclin-dependent kinase 5 in the glomeruli of rats with diabetic nephropathy.
    The American journal of the medical sciences, 2013, Volume: 345, Issue:6

    Topics: Animals; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Intermediate Filament Proteins; Kidney Glomerulus; Male; Nerve Tissue Proteins; Nestin; Protein Kinase Inhibitors; Purines; Rats; Rats, Wistar; Roscovitine; Streptozocin; Vimentin

2013